Glass House Brands (GLAS) Free Cash Flow (2020 - 2026)

Glass House Brands' (GLAS) quarterly Free Cash Flow came in at -$8.2 million in Q1 2026, down 189.56% year-on-year from $9.2 million in Q1 2025, and up 67.28% on a QoQ basis from -$25.1 million in Q4 2025.

Glass House Brands (GLAS) Free Cash Flow (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Free Cash Flow data on file, last reported at -$8.2 million in Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 189.56% year-over-year to -$8.2 million in Q1 2026; TTM through Mar 2026 was -$2.5 million, a 109.47% decrease from a year earlier, with the FY2025 full-year figure at $14.8 million, down 17.99% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$8.2 million, up from -$25.1 million in the prior quarter.
  • Over the last five years, Free Cash Flow for GLAS reached as high as $21783.2 billion in Q3 2023 and fell as low as -$25.1 million in Q4 2025.
  • Historically, Free Cash Flow has averaged $2191.9 billion across 5 years, with a median of $5.5 million in 2023.
  • Across the five-year window, Free Cash Flow surged 207931285.36% in 2023 and sank 189.56% in 2026, its largest moves.
  • Year by year, Free Cash Flow stood at $15478.4 billion in 2022, then slumped by 100.0% to -$4.6 million in 2023, then slumped by 113.75% to -$9.8 million in 2024, then slumped by 155.03% to -$25.1 million in 2025, then jumped by 67.28% to -$8.2 million in 2026.
  • Per Business Quant data, the three most recent Free Cash Flow figures were -$8.2 million in Q1 2026, -$25.1 million in Q4 2025, and $3.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -208.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 291.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -373.37 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 363.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 348.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 144.40 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -38.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -8.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.21 Mn
Mar 31, 2026 -8.21 Mn
Dec 31, 2025 -25.09 Mn
Dec 31, 2025 -25.09 Mn
Sep 30, 2025 3.57 Mn
Sep 30, 2025 3.57 Mn
Jun 30, 2025 27.20 Mn
Jun 30, 2025 27.20 Mn
Mar 31, 2025 9.17 Mn
Mar 31, 2025 9.17 Mn
Dec 31, 2024 -9.84 Mn
Dec 31, 2024 -9.84 Mn
Sep 30, 2024 14.59 Mn
Sep 30, 2024 14.59 Mn
Jun 30, 2024 12.81 Mn
Jun 30, 2024 12.81 Mn
Mar 31, 2024 530,000.00
Mar 31, 2024 530,000.00
Dec 31, 2023 -4.60 Mn
Dec 31, 2023 -4.60 Mn